Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Tapering vs Standard Steroids for Nephrotic Syndrome
NCT00308321Phase 4Unknown
- Sponsor
- Institute of Child Health
- Start
- Sep 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisolone in nephrotic syndrome (2 arms), sponsored by Institute of Child Health. Primary endpoints: Time to first relapse at 5 months and Assessment of steroid induced morbidity at 5 months. Status: unknown.
02
Drugs
prednisolone
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT00308321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308321.